Treatment of frailty can improve outcomes for transplant recipients

The impact of frailty on outcomes for organ transplant recipients is gaining widespread attention in transplant programs around the world. In numerous studies, frailty has been associated with increased length of stay,  increased hospitalizations, increased costs, and increased mortality.

Read more

In Barrett’s epithelial cells, weakly acidic bile causes DNA damage with response and repair mediated by p38

Gastroesophageal reflux disease (GERD) can cause Barrett’s esophagus, a change in the lining of the esophagus that predisposes to a type of cancer called esophageal adenocarcinoma.  It is thought that the reflux of strong acid and bile salts from the stomach into the esophagus contributes to the development of this cancer.  In an attempt to prevent esophageal adenocarcinoma, physicians prescribe proton pump inhibitors (PPIs) for patients with Barrett’s esophagus.  These PPIs reduce the amount of acid produced by the stomach, but they do not stop the reflux of gastric contents into the esophagus.  The gastric contents of patients taking PPIs are weakly acidic and they contain bile salts, and our team at Baylor Scott & White Research Institute’s Center for Esophageal Research were concerned that this material still might be damaging to the esophagus.  

Read more

New insights into hepatic encephalopathy

Hepatic encephalopathy (HE), which manifests as decreased brain function, is a common, debilitating condition seen in patients with liver disease. The symptoms can range from attention deficits to coma and are largely reversible. The healthcare burden of HE is profound: HE is the leading cause of 3-month readmission for patients with cirrhosis in North America and is associated with increased mortality. Researchers at Baylor Scott & White Research Institute have summarized the latest insights into the pathophysiology and treatment of HE in a recent issue of Nutrition in Clinical Practice.

Read more

Advanced genome sequencing identifies new genetic links for leukodystrophy

During the last decade, incredible improvements in the speed, accuracy and cost-effectiveness of whole-genome sequencing have accelerated our understanding of genetic disorders. An international Leukodystrophy Study Group, including researchers with Baylor Scott & White Research Institute (BSWRI), has used these next-generation sequencing methods to reveal the genetic abnormalities in a cohort of 71 persistently undiagnosed individuals with suspected leukodystrophy. Leukodystrophies are rare genetic disorders that disrupt the myelin sheath, which forms the white matter in the brain.

Read more

Improved criteria for diagnosing osteomyelitis

Prevalence of the bone infection osteomyelitis (OM) has increased along with the increased prevalence of diabetes. It is estimated that OM is a complication for at least 10% of diabetic foot ulcers and approximately 50% of severe cases. Delays in the diagnosis and treatment of OM can lead to poor patient outcomes and high healthcare costs. However, an accurate and timely diagnosis of OM is hindered by a lack of clear guidelines for histopathological assessment. Therefore, researchers from Baylor Scott & White Research Institute, along with their collaborators, have created a new diagnostic framework for OM.

Read more